Close

Spark Therapeutics (ONCE) PT Raised to $114.50 at BMO Capital, Remains Sidelined Following Acquisition Feb 25, 2019 04:02PM
Spark Therapeutics (ONCE) PT Lowered to $46 at BMO Capital Feb 19, 2019 03:38PM
Spark Therapeutics (ONCE) PT Lowered to $48 at BMO Capital Nov 6, 2018 03:55PM
BMO Capital Downgrades Spark Therapeutics (ONCE) to Market Perform Aug 7, 2018 04:23PM
UPDATE: Spark Therapeutics (ONCE) PT Raised to $98 at BMO Capital Following Management Meeting Jun 25, 2018 08:31AM


Feb 20, 2018 12:23PM Spark Therapeutics (ONCE) PT Lowered to $64 at BMO Capital
Jan 25, 2018 06:22AM Spark Therapeutics (ONCE) PT Raised to $66 at BMO Capital Following 'Sound' Novartis Partnership
Jan 3, 2018 01:41PM Spark Therapeutics (ONCE) PT Lowered to $64 at BMO Capital After Luxturna Price, Keeps Outperform
Dec 11, 2017 12:07PM Spark Therapeutics (ONCE) PT Lowered to $73 at BMO Capital, But Says Weakness 'Overdone'
Oct 13, 2017 06:07AM Spark Therapeutics (ONCE) PT Raised to $101 at BMO Capital
Oct 10, 2017 09:30AM Spark Therapeutics (ONCE): Luxturna Briefing Docs Reinforce Jan Approval - BMO
Aug 2, 2017 11:41AM Spark Therapeutics (ONCE) PT Raised to $89 at BMO Capital
Apr 6, 2017 11:03AM BMO Capital Reiterates Outperform Rating and $69 PT on Spark Therapeutics (ONCE) Following SPK-9001 Data Update
Dec 20, 2016 06:12AM BMO Capital Starts Spark Therapeutics (ONCE) at Outperform